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Introduction
 Cancer is uncontrolled growth of cells. It can affect 
almost any part of the body. The growths often invade 
surrounding tissue and can metastasize to distant sites 
(WHO, 2011). Cancer is caused by mutations in the 
DNA. Normal cells repair the mutation or simply 
die when a mutation occurs whereas cancerous cells 
continue to survive with the mutations and they grow 
in an uncontrolled manner until a mass of cells known 
as tumor is created. Often the tumor interferes with the 
normal functioning of healthy tissues and can spread to 
other parts of the body (Tompa, 2007).
 Cervical cancer is a malignant neoplasm of the 
cervical area. It is an important women’s health problem 
in developing countries, killing 270,000 women each year. 
It is the third most common cancer overall and the leading 
cause of death from cancer among women in developing 
countries. At least 370,000 new cases are identified each 
year (WHO, 2010). Current cancer chemotherapy can 
damage or kill the rapid dividing and healthy cell but 
causes serious side effects such as nausea, anemia, and hair 
loss. In addition, the cost of chemotherapy drug is high as 
compared to the natural compound from medicinal plants.
 Goniothalamin, a natural occurring styryl-lactone and 
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Abstract
 Cancer is one of the major health problems worldwide and its current treatments have a number of undesired 
adverse side effects. Natural compounds may reduce these. Currently, a few plant products are being used to 
treat cancer. In this study, goniothalamin, a natural occurring styryl-lactone extracted from Goniothalamus 
macrophyllus, was  investigated for cytotoxic properties against cervical cancer (HeLa), breast carcinoma 
(MCF-7) and colon cancer (HT29) cells as well as normal mouse fibroblast (3T3) using MTT assay. Fluorescence 
microscopy showed that GTN is able to induce apoptosis in HeLa cells in a time dependent manner. Flow cytometry 
further revealed HeLa cells treated with GTN to be arrested in the S phase. Phosphatidyl serine properties 
present during apoptosis enable early detection of the apoptosis in the cells. Using annexin V/PI double staining 
it could be shown that GTN induces early apoptosis on HeLa cells after 24, 48 and 72 h. It could be concluded 
that goniothalamin showing a promising cytotoxicity effect against several cancer cell lines including cervical 
cancer cells (HeLa) with apoptosis as the mode of cell death induced on HeLa cells by Goniothalamin was. 
Keywords: Goniothalamin - HeLa cervical cancer cell line - fluorescence microscopy - cellular DNA content - apoptosis.
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extract from Goniothalamus SPP. it is a novel compound 
with putative anti-cancer properties (Lin and Pihie, 2003; 
Chen et al., 2005; Al-Qubaisi et al., 2011). Goniothalamin 
extracted from Goniothalamus andersonii had been able 
to induce cytotoxicity in a variety of cancer cell lines 
including cervical (HeLa), gastric (HGC-27), kidney (768-
0), breast carcinomas (MCF-7, T47D and MDA-MB-231) 
and leukemia (HL-60, Jurkat and CEM-SS) (Rajab et al., 
2005; Inayat-Hussain et al., 2010). Goniothalamin has 
been proved to be only cytotoxic to ovarian cancer cell line 
(Caov-3) without causing cell death in normal kidney cell 
(MDBK) as happened in tamoxifen or taxol treated cells 
(Lin and Pihie, 2003). In addition, goniothalamin showed 
lower toxicity to normal liver Chang cell line as compared 
to doxorubicin (chemotherapy drug) (Al-Qubaisi et 
al., 2011). Goniothalamin is a promising antitumor 
agent against cancerous cell lines (Wattanapiromsakul 
et al., 2005). Cytotoxicity of goniothalamin in human 
leukemia (HL-60 and Jurkat) and human breast carcinoma 
(MDA-MB-231) occurs via apoptosis after treated with 
goniothalamin (Chen et al., 2005; Inayat-Hussain et al., 
2010). 
 In this study, goniothalamin, a natural occurring 
styryl-lactone and extract from root of Goniothalamus 
macrophyllus is used to investigate the cytotoxic 
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properties against several cancer cell lines. Furthermore, 
this study carried out to study the mechanism of apoptosis 
induction of goniothalamin on HeLa cells by determines 
the DNA content and Phosphatidyl Serine properties.
Materials and Methods
Goniothalamin extract
 Dried and powdered root (500g) of Goniothalamus 
macrophyllus were extracted with dichloromethane and 
concentrated. Fifty g of brown resin was subjected to silica 
gel chromatography with gradient of hexane/ethyl acetate 
(8:2) which gave goniothalamin 5g (colorless crystal), 
structurally confirmed by comparing 1H and 13C-NMR 
data with those reported. 13C NMR: δ 29.87, 77.95, 
121.60, 125.72, 126.72, 128.71, 133.10, 135.80, 144.76 
and 163.90.
Cells and cell culture
 cervical cancer (HeLa), breast carcinoma (MCF-7), 
colon cancer (HT29) and Normal mouse fibroblast cells 
(3T3) obtained from animal tissue culture laboratory, 
UniSZA. cell lines were grown in 25 cm² tissue culture 
flasks (Nunclon TM, Nunc) at 37°C, 5%CO2 and 90% 
humidity in RPMI -1640 medium (Sigma Chemical 
Company), containing 10% fetal bovine serum (Culture 
lab), penicillin (100 IU/ml) and streptomycin (100 µg/ml). 
The cells were grown confluence, which could be observed 
under an inverted microscope and sub – cultured at three 
to four days interval.
MTT Cytotoxicity Assay
 All cell lines were trypsinized and counted using 
hemocytometer then were seeded in 96-well micro plate 
at 5×105 cells/ml and then incubated at 37oC in 5%CO2 
to allow cells attachment. The medium was removed 
and replaced with fresh medium containing various 
concentrations of goniothalamin starting with the highest 
concentration of 60 µg /ml (two folded dilution). Cells 
were incubated at 37oC, 5%CO2 for 72 hours. Each 
concentration was assayed in triplicates (n=3). Seventy-
two hours later, 20 µl of MTT (5 mg/ml) solution was 
added to each well and then the plate was further incubated 
for 4 h. All remaining supernatant were removed and 150 
µl of DMSO was added to dissolve the formed crystal 
formazan. MTT assay reading was performed using 
ELISA plate reader (Tecan 200, USA). 
The MTT Cell Proliferation Assay
 To confirm anti-proliferative effects of goniothalamin 
on HeLa cells, MTT cell proliferation assay was carried 
out. In this assay, two different concentrations of compound 
with cells were prepared together with control. The 
concentration chosen were IC25 and IC50 concentrations 
(3.2 and 1.2 µg/ml). Each sample was assayed in triplicate, 
and control samples include cells without goniothalamin. 
The cells were treated by goniothalamin for 24, 48, and 
72 hours. At the end of incubation periods, 20μl of MTT 
solution (5 mg/ml MTT dissolved in PBS) were added to 
each well containing cells and the plate was incubated at 
37ºC in an atmosphere of 5%CO2 for 4 hours. After that, 
most of the medium was removed, then a volume 100 µl 
of DMSO (dimethyl sulfoxide) was added into the wells to 
soluble the crystals. Finally the absorbance was measured 
by ELISA reader at a wavelength of 570 nm. Graphs (OD 
of samples against time) were plotted to determine the 
growth rates of cells in a given values.
Acridine Orange (AO) and Propodium Iodide (PI) Double 
Staining using Fluorescent Microscopy
 HeLa cells were quantified using propidium iodide 
(PI) and acridine-orange (AO) double staining according 
to standard procedures and examine under fluorescence 
microscope (Lieca attached with Q-Floro Software) 
(Mishell et al., 1980; Ali, 2011). 
 Cells suspension was mixed with an equal volume 
of staining solution (1 : 1) containing 10 μg/mL acridine 
orange and 10 μg/mL propium iodide (dissolved in PBS) 
and observed under fluorescence microscope within 30 
minutes. The viable (green intact cells), apoptotic (green 
shrinking cells with condensed of fragmented nucleus), 
and necrotic (red cells) were the morphological changes 
that were examined under fluorescence microscope.
 HeLa cells were seeded in six-well plate and incubated 
at 37 oC in 5%CO2 atmosphere. Twenty-four hours later, 
the medium in each well was removed and replaced with 
Goniothalamin at IC50 concentration dissolved in medium 
and incubated at 37oC in 5%CO2 atmosphere for 24, 48, 
and 72 h. After incubation period, Cells suspension was 
mixed with an equal volume of staining solution (1 : 
1) containing 10 μg/mL acridine orange and 10 μg/ml 
propium iodide (dissolved in PBS) and observed under 
fluorescence microscope within 30 minutes. The viable 
(green intact cells), apoptotic (green shrinking cells with 
condensed of fragmented nucleus), and necrotic (red cells) 
were the morphological changes that were examined 
under fluorescence microscope (Leica, Germany). Each 
experiment was assayed three times (n=3) to provide 
a useful quantitative evaluation. Viable, apoptotic and 
necrotic cells was quantified in a population of 200 cells. 
The results were expressed as a proportion of the total 
number of the cells examined. 
 
Analysis of Cellular DNA Content Using Propidium Iodide
 HeLa cells at a concentration of 1x106 cells/ml were 
seeded into 6-well plate in 2 ml culture medium with a 
concentration of IC50 value of goniothalamin and were 
incubated at 37ºC in an atmosphere of 5%CO2 for 24,48 
and 72 hours. Some wells were left with no treatment to be 
used as a control. After the incubation period, the cultured 
cells were harvested using trypsin and centrifuged. After 
incubation, the cells were detached and stained by using 
the Cycle TEST TM PLUS DNA Reagent Kit. Cell cycle 
was read using the Cell Quest software within 3 hours. 
 Flow cytometry (Annexin V/PI double staining): HeLa 
cells at a concentration of 1 X 106 cell/ml were seeded 
into the 6-well plate and treated with IC50 concentration 
of Goniothalamin. After 24, 48 and 72 h incubation, the 
cells were detached and stained by using PE Annexin V 
Apoptosis Detection Kit I. All samples were read by the 
flow cytometer.
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Statistical Analysis 
 Data was expressed as mean±SD. Statistical analysis 
was performed with Student’s t-test using the independent 
t-test (SPSS version 15). Differences were considered 
significant at P=0.05. 
Results 
MTT Cytotoxicity Assay
 Cytotoxicity of goniothalamin was evaluated 
using MTT assay. The IC50 values of gonoitahalamin 
concentrations that kill 50% of treated cell lines compared 
to untreated cells were 3.2±0.72, 6.6±0.92, 3.8±1.10 and 
>10 µl/ml for (HeLa), breast carcinoma (MCF-7), colon 
cancer (HT29) and Normal mouse fibroblast cells (3T3), 
respectively (Table 1). 
 
The MTT Cell Proliferation Assay
 The effect of goniothalamin on cells proliferation was 
studied in vitro, by using the MTT proliferation assay 
with HeLa cell lines. In the assay, both concentrations of 
GTN, IC50 and IC25, were used. Untreated cells were used 
as control. To determine the changes in the numbers of 
cells in the wells during the experiment, cells proliferation 
had to be measured 24, 48 and 72 hours after the start 
of the incubation period. GTN treatment on HeLa cells 
showed that the optical density was lower in both 
concentrations, IC50 and IC25, than controls. Whereas 
GTN treatment on HeLa cells with the IC50 values showed 
that the optical density was lower than inoculation with 
the IC25 values. This optical density is in proportion to 
the number of variable cells. Figure 1 shows that the 
growth rates decreased in the treated cells as compared 
with the untreated cells whereas inoculation with a higher 
concentration (IC50) decreased the growth rate more than 
low concentration (IC25). On the other hand, the percentage 
of non-viable cells treated with IC25 value was 28% (day 
1), 38% (day 2) and 45% (day 3). But the percentage of 
non-viable cells treated with IC50 values were 38% (day 
1), 45% (day 2) and 48% (day 3) (Figure 2). 
 
Acridine Orange (AO) and Propodium Iodide (PI) Double 
Staining using Fluorescent Microscopy
 fluorescent microscope was conducted to study of 
morphological changes of cell death mode induced by 
goniothalamin after 24, 48 and 72 h. Acridine orange 
(AO) and propidium iodide (PI) staining was used.  Viable 
cells displayed green fluorescence with the appearance of 
circular cell; intact DNA and nucleus give a round and 
green nuclei.  The early apoptotic cells have fragmented 
DNA which gives several green colored nuclei and cell 
blebbing. Late apoptotic and necrotic cell’s DNA would 
be fragmented and stained orange and red (Figure 3)
 Besides the study of morphological changes, the 
percentage of viable, apoptotic and necrotic cells also 
recorded in Table 2 and plotted as a graph in Figure 4. The 
percentage of apoptotic cells in untreated cells slightly 
increased from 0.67% after 24 h to 5.33% and 7% after 
48 and 72h, respectively (Figure 5). Whereas, cells treated 
with goniothalamin at IC50 concentration, the percentage 
of apoptotic cells increased rapidly from 37% after 24h 
to 53% and 63% after 48 and 72h, respectively.  
Analysis of Cellular DNA Content Using Propidium Iodide
 The DNA Content of HeLa cells were monitored by 
 
Figure 1. MTT Proliferation Assay for IC50 and IC25 
Goniothalamin Concentrations (3.2 and 1.2 µg/ml) 
Against HeLa Cells at 24, 48 and 72 Hours Post-
Treatment. The growth rates decreased in the treated cells 
as compared with the untreated cells whereas inoculation 
with a higher concentration of virus (IC50) decreased the growth 
rate more than low concentration (IC25)
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A  B  C   Figure 2. The Percentage of Viable and Non-
viable HeLa Cells in Population after Treated with 
Goniothalamin after 24, 48 and 72 h. A) untreated cells, 
B) HeLa cells treated with IC25 Goniothalamin concentration 
(1.2 µg/ml), C) HeLa cells treated with IC50 Goniothalamin 
concentration (3.2 µg/ml)
              A)                               B)                       C)
 
A  B   
C  D  
 Figure 3. Fluorescence Microscopy Examination of 
HeLa Cell Line (Magnification 200X). A) Untreated HeLa 
cells, B) HeLa cells treated with Goniothalamin after 24 h, C) 
HeLa cells treated with Goniothalamin after 48 h, D) HeLa cells 
treated with Goniothalamin after 72 h.
 
Figure 4. Flourecent Microscopy Examination. 
Percentage of apoptotic cells, necrotic cells and viable cells in 
HeLa cell population with gonithalamin treatment after 24 48 
and 72 h. HeLa cell death via apoptosis increased significantly 
(*P < 0.05) in time-dependent manner
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Table 1. Cytotoxicity of Goniothalamin against Various 
Cell Lines   
Cell line IC50 value (μg/ml)
Cervical cancer (HeLa) 3.2±0.72
Breast carcinoma (MCF-7) 6.6±0.92
Colon cancer (HT29) 3.8±1.10
Normal mouse fibroblast cells (3T3) >10
Table 2. Percentages of Apoptotic, Necrotic and Viable 
HeLa Cells after 24 and 48 h
HeLa cells and Treatment Apoptotic Necrotic Viable
  cells % cells % cells %
Untreated HeLa cells after 24 h 0.67 3.67 95.66
Untreated HeLa  cells after 48 h 5.33 6.67 88.00
Untreated HeLa  cells after 72 h 7.00 3.33 89.67
GN  treated HeLa cells after 24h 37.00 11.00 52.00
GN  treated HeLa cells after 48h 53.00 19.20 27.80
GN  treated HeLa cells after 72h 63.00 26.67 10.33
Table 4. Cell Cycle Analysis of Cervical Cancer Cells 
(HeLa) at 24h and 48h Treated with Goniothalamin
Cell cycle phase Treated with IC50 Goniothalamin (%)
 24H 48H
SUB-G1 5.91 27.99
G1 64.66 43.10
S 23.17 25.90
G2/M 7.08 3.76
flow cytometry after propidium iodide staining nuclei. 
Goniothalamin induced a significant time-dependent 
increase in the proportion of sub-G1 in HeLa cell 
population. However, a slight increase was observed at 
Sub G1 phase of untreated cervical cell (HeLa) over time. 
Tables 3 and 4 show that the percentages of the  treated 
cells in Sub-G1 increased  from 5.91% at 24 hours to 
27.99% at 48 h while the percentages in untreated cells 
increased from 2.44% at 24 hours to 6.62% at 48 h 
(p<0.005). 
 On the other hand DNA histogram showed that 
goniothalamin increased the population of cells at S phase 
in a time-dependent manner (Figure 6). The S population 
increased significantly from 6.17% and 8.53% in the 
untreated cells to 23.17% and 25.92% in cells treated with 
IC50 goniothalamin for 24 and 48h, respectively Tables 3 
and 4. While concomitantly the G1 population decreased 
from 78.38 %and 69.27% in the untreated cells to 64.66% 
and 43.10% in the treated cells for 24 and 48h, respectively 
Tables 3 and 4. Similarly the G2/M population decreased 
from 12.98% and 15.58% in the untreated cells to 7.08% 
and 3.76% in the treated cells for 24 and 48h, respectively 
Tables 3 and 4. 
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Figure 5. Cell Cycle Analysis of Cervical Cell Cancer 
Treated with Goniothalamin at IC50 Concentration. A) Untreated cells, B) Treatment after 24h, C) Treatment after 48 h.
A B  Figure 6. Analysis of the Cell Cycle on Cervical Cancer 
Cells (HeLa) after 24h and 48h. A) Untreated HeLa cells, 
B) HeLa cells treated with Goniothalamin. 
A B  
  A)            B)
A     B  
Figure 7. Contour Diagram of Annexin V/PI Flow 
Cytometry. A) untreated HeLa cells, B) HeLa cells  at 24 
h post-inoculation of IC50 value of Goniothalamin. Lower left 
quadrants show viable cells, excluding PI and negative for 
Annexin V binding. The upper right quadrants contain the non-
viable, necrotic cells, positive for Annexin V and PI uptake. 
Lower right quadrants represent the apoptotic cells, Annexin V 
positive and PI negative.  
Flow cytometry (Annexin V/PI double staining)
 Apoptotic cells exclude all dyes which are in use for 
cell viability assays, such as PI, while necrotic cells do 
not. In cells with a damaged cell membrane PI induces a 
red fluorescence on the DNA, whilst it is excluded by cells 
with a preserved cytoplasm membrane. Hence during the 
initial phase of apoptosis, the cells are still able to exclude 
PI and therefore do not show any red fluorescence signal, 
similar to that of living cells. Figure 7 showed the results of 
Annexin V/PI flow cytometry of HeLa cells after treatment 
with IC50 value of goniothalamin. Untreated cell was 
found in the lower left quadrant of the cytograms, these 
viable cells excluded PI and were negative for Annexin 
V binding. The upper right quadrant represents the non-
viable, necrotic cells, positive for Annexin V binding and 
showing PI uptake. The lower right quadrant represents 
the apoptotic cells, Annexin V positive and PI negative, 
demonstrating Annexin V binding and cytoplasmic 
membrane integrity (Figure. 11). The Annexin V/PI – 
apoptotic cell population for HeLa cell line increased from 
6.4%in untreated cells, to 26.45% in treated cells at 24 h 
post-infection.
Table 3. Percentages of Untreated Cervical Cancer 
Cells at 24h and 48 h    
Cell cycle phase HeLa cells (%)
 24H 48H
SUB-G1 2.44 6.62
G1 78.38 69.27
S 6.17 8.53
G2/M 12.98 15.58
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Discussion
 Cell death in mammalian cells are divided into two 
morphologically and biochemically distinct modes 
namely apoptosis and necrosis (Doyle and Griffiths, 
1998). Apoptosis is an organized, pre-programmed 
response of cell to shifting of environmental conditions. 
Characteristics of apoptotic cell include cell shrinkage, 
nuclear and DNA fragmentation and breaking up of the 
cell into membrane-bounded vesicles, termed ‘apoptotic 
bodies’, which are subsequently ingested by macrophages 
(Doyle and Griffiths, 1998). Apoptosis plays a vital role 
in regulating growth, development and immune response, 
and also clearing abnormal cells (Fan et al., 2005). 
This apoptosis program becomes important in medical 
study in order to cure the cancerous cell without give 
the inflammatory effect. Aberrant cell death processes 
may underlie many human diseases including cancers, 
autoimmune, neurodegenerative and immunodeficiency 
disorders (Baehrecke, 2002).  
Cytotoxic has been defined as the cell killing property 
of a chemical compound independent from the mechanism 
of death (Graham-Evans et al., 2003). Cytotoxicity assay 
is an appropriate method for screening new substances 
within a short time in order to determine cytotoxicity on 
cancer cells (Alley et al., 1988). The effective dose for a 
50% reduction in cell number for plants products to be 
considered cytotoxic should be less than 20 µg/ml (Geran 
et al., 1972 ).   
MTT cytotoxicity  assay used to measure the  cytotoxic 
effect of goniothalamin (GTN) on cervical cancer (HeLa), 
breast carcinoma (MCF-7), colon cancer (HT29) and 
Normal mouse fibroblast cells (3T3)  measure of cytotoxic 
effect and The IC50 concentration that kill 50% of the cells 
was determined graphically after 72 h. In screening result, 
GNT has shown broad spectrum cytotoxicity and It had 
most active cytotoxic activity cervical cancer (HeLa) but 
not on Normal mouse fibroblast cells (3T3). These results 
conducted to other studies investigated the cytotoxic effect 
of Goniothalamin towards human breast cancer, vascular 
smooth muscle cells (VSMCs), Jurkat leukemia cells, 
HL-60 leukemia cells, Chinese hamster ovary (CHO) 
and hepatoblastoma HepG2 cells (Ali et al., 1997; Pihie 
et al., 1998; Inayat-Hussain et al., 1999; Inayat-Hussain 
et al., 2003; Nasir et al., 2004; Chen et al., 2005; Chan et 
al., 2006; Al-Qubaisi et al., 2011). 
In this study, GTN have indicated significant growth 
inhibition in HeLa cell line at low concentration of 
IC50 values. MTT proliferation assay was carried out to 
determine the growth rate of cells. A linear relationship 
between the formazan generated and the number of viable 
cells was demonstrated, together with time-dependent 
growth characteristics for HeLa cells (Ferrari et al., 1990). 
GTN treatment on HeLa cells cell lines showed significant 
decrease in growth rate compared with control. Whereas 
treatment with high concentration (IC50 value) showed that 
the growth rates of the cells were more decreased than of 
low concentration (IC25 values). On the other hand the 
percentage of non-viable cells on both cell lines increased 
with the increasing period of treatment.
However, MTT cytotoxic results of GTN on HeLa 
cells have been further supported with morpgological 
study using fluorescent microscopy Acridine Orange 
Propidium Iodide staining assay and flow cytometric 
analysis of cell cycle.
The apoptotic features were confirmed and the 
percentage of apoptotic cells was determined from 
at least 300 counted cells observed under fluorescent 
microscope. The calculation of apoptotic cells is described 
as the percentage of apoptotic cells and apoptotic bodies 
within the overall population of cells.  The percentage of 
apoptotic cells and the graph showed that the percentage of 
apoptotic cells treated with goniothalamin was increasing 
among the time. These distinctive morphological features 
form the basis of some of the most widely used techniques 
for the identification and quantification of apoptosis, 
and thus morphologic description using Phase Contrast 
microscopy and fluorescence microscopy remains one of 
the best ways to define apoptosis (Doonan and Cotter , 
2008).  
The quantitative analysis of cell cycle is very important 
in the study of molecular mechanism of cell death and 
cell cycle progression (Tao et al., 2004). Untreated 
and treated HeLa cells were evaluated for apoptosis by 
measuring the amount of apoptotic cells using of DNA 
flow cytometry (FCM). Flow cytometric analysis of cell 
cycle measures the apoptotic changes in cells by staining 
them with DNA dyes (Telford et al., 1994). Apoptotic 
cells, due to a change in membrane permeability, showed 
an increased up-take of the vital dye, PI, compared to 
live cells (Nicoletti et al., 1991; Telford et al., 1994). 
This method is useful for quantitative estimates of the 
fractions of cells in the different phases of the cell cycle 
(Ali et al., 2011). In this  study goniothalamin treatment 
on HeLa cells produced S phase cell cycle accumulation 
with a large increase in the sub-G1 which mean there was 
a relationship between goniothalamin-induced S  phase 
arrest and apoptosis(p<0.001). A study of cell cycle pattern 
has been documented that goniothalamin treatment causes 
cell cycle arrest and cell death maximally at G2/M phase 
(Chen et al., 2005). Another study demonstrates that GTN 
arrested cell cycle at G0/G1 in SK-Hep1, and at G2/M in 
Hep-3B cells (Cheng-Hui , 2008). These results concurred 
with the previous results to suggest that goniothalamin 
induce apoptosis on HeLa cells more extensively with 
increasing in time. 
Change in plasma membranes is the earliest features of 
apoptosis. In apoptotic cells, the membrane phospholopid, 
phosphotidylserine (PS) is translocated from the inner to 
the outer leaflet of the plasma membrane thereby exposing 
PS to the external cellular activity (Lawen, 2003). 
Annexin binding assay is a method permits the detection 
of the early phases of apoptosis before the loss of cell 
membrane integrity (Vermes et al., 1995; Aubry et al., 
1999). The principle of Annexin V staining method used 
is the conjugation of Annexin V to phosphotidylserine of 
the apoptosis cells and in conjunction of dye Propodium 
Iodide which binds to cells at different stage and 
distinguishes apoptosis cells with necrotic cells (Tao et al., 
2004). Apparently, the results indicate that the percentage 
of cells in early apoptosis of the cervical cancer cell 
(HeLa) treated with Goniothalamin appeared after 24 hr. 
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